Effect of omega−3 fatty acdid supplementation on reduce body weight and body fat mass in obesity

A case study with an evidence-based approach

  • Lidya Anissa Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
  • Wiji Lestari 1. Faculty of Medicine Universitas Indonesia – Dr. Cipto Mangunkusumo Hospital 2. University of Indonesia Hospital, Depok, Indonesia
Keywords: obesity, omega−3 fatty acids, body weight, body composition, fat mass

Abstract

Background: Obesity is a public health problem, especially in developing countries. Providing Omega−3 supplementation has benefits to reduce body weight and body fat mass. Objective: This study aims to determine the effect of omega−3 supplementation on weight loss and body fat mass in obesity. Methods: This study used a literature search using advanced queries in the databases PubMed, Scopus, ProQuest, Cochrane Library, and combined MeSH terms with Title/Abstract. The collected literature is discarded if there are duplicates, then literature that meets the eligibility criteria is filtered. We used the Oxford Center for Evidence-Based Medicine as a means of critical appraisal and determining the level of evidence of the selected literature. Results: Four chosen study were selected. The first study involved 39 adults with obesity, there was a weight loss of 6.04 kg in the group given omega−3 supplementation of 6 g/day for 8 weeks compared to the placebo group 5.4 kg and there was a decreased in body fat mass in the intervention group. The second study did not show a significant result. The third study on 65 women showed a weight loss of 3.07 kg in the group given omega−3 consisting of 1.08 g EPA and 0.72 g DHA compared to 1.16 kg in the placebo group for 12 weeks. In the fourth study, a systematic review study, there was no conclusive result. Conclusion: Omega−3 fatty acid supplementation could be beneficial in reducing weight in obese patients with dietary modification.

Downloads

Download data is not yet available.

Author Biographies

Lidya Anissa, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
Departement of nutrition,
Wiji Lestari, 1. Faculty of Medicine Universitas Indonesia – Dr. Cipto Mangunkusumo Hospital 2. University of Indonesia Hospital, Depok, Indonesia
Departement of Nutrition

References

Lim JU, Lee JH, Kim JS, Hwang YI, Kim TH, Lim SY, et al. Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients. Int J Chron Obstruct Pulmon Dis. 2017;12:2465-75.

RI KK. RISKESDAS 2018.

Miller GD. Appetite regulation: hormones, peptides, and neurotransmitters and their role in obesity. Am J Lifestyle Med. 2017;13(6):586-601.

Lasar D, Rosenwald M, Kiehlmann E, et al. Peroxisome proliferator-activated receptor gamma controls mature brown adipocyte inducibility through glycerol kinase. Published online. 2018:760-773.

Moraes-Vieira PM, Yore MM, Dwyer PM, Syed I, Aryal P, Kahn BB. RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance. Cell Metab. 2014;19:512-26.

Mancini C, Gohlke S, Carrizo FG, Zagoriy V. Identification of biomarkers of brown adipose tissue aging highlights the role of dysfunctional energy and nucleotide metabolism pathways. Sci Rep. 2021:1-15.

Kawai T, Autieri M V, Scalia R. Inflammation : From Cellular Mechanisms to Immune Cell Education Adipose tissue inflammation and metabolic dysfunction in obesity. 2024;(December 2020).

Ana ML, Mart EHJA, Alfredo J, Mar M. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. Elsevier Inc. 2015.

Albrecht-Schulte K, Kalupahana NS, Ramalingam L, Wang S, Rahman SM, Robert-McComb J, et al. Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update. J Nutr Biochem. 2018;58:1–16.

Albrecht-Schulte K, Sudheera N, Ramalingam L, Wang S. ScienceDirect. 2018;58(2017):1-16.

Munro IA, Garg ML. Prior supplementation with long chain omega-3 fatty acids promotes weight loss in obese adults: a double-blinded randomized controlled trial. Food Funct. 2013;4(4):650-8.

Noreen EE, Sass MJ, Crowe ML, Pabon VA, Brandauer J, Averill LK. Effects of supplemental fish oil on resting metabolic rate, body composition, and salivary cortisol in healthy adults. J Int Soc Sports Nutr. 2010;7.

Defina LF, Marcoux LG, Devers SM, Cleaver JP, Willis BL. Effects of omega-3 fatty acids supplementation in combination with diet and exercise on weight loss and body composition. 2011;(10).

Mendes F, Munhoz L, Gonçalves B. Effects of omega-3 fatty acids supplementation on body weight and body fat mass: a systematic review. Clin Nutr ESPEN. 2021;44.

Ali S, Mostafavi S, Akhondzadeh S. Omega-3 fatty acids supplementation effects on body weight and depression among dieter women with co-morbidity of depression and obesity compared with placebo: a randomized clinical trial. Clin Nutr ESPEN. 2018:1-7.

Salman HB, Salman MA, Akal EY. The effect of omega-3 fatty acids supplementation on weight loss and cognitive function in overweight or obese individuals on weight-loss diet. Nutr Hosp. 2022;39(4):803-13.

Jump DB, Botolin D, Wang Y, Xu J, Demeure O, Christian B. Docosahexaenoic Acid (DHA) and Hepatic Gene Transcription. NIH Public Access. 2009;153(1):3-13.

Innes JK, Calder PC. Marine omega-3 (n-3) fatty acids for cardiovascular health: an update for 2020. 2020:1-21.

Ghasemifard S, Hermon K, Turchini GM, Sinclair AJ. Metabolic fate (absorption, beta-oxidation, and deposition) of long-chain n-3 fatty acids is affected by sex and by the oil source (krill oil or fish oil) in the rat. Br J Nutr. 2015;114:684-92.

Sandoval C, Nahuelqueo K, Mella L, Recabarren B, Souza-Mello V, Farías J. Role of long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic, in the regulation of gene expression during the development of obesity: a systematic review. 2023:1-15.

Submitted

2024-05-14
Accepted
2024-12-27
Published
2025-02-28